CNS demyelination during tofacitinib therapy: First report

Induction of Jak/STAT Signaling by Activation of the Type 1 TNF Receptor

Danqun Guo, James D. Dunbar, Chuan Yang et al. · The Journal of Immunology · 1998 · 170 citations · Full text

Jak/stat Signaling, Immunology, Immunologic Mechanism +21

Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events

Amy Kunchok, Allen J. Aksamit, John M. Davis et al. · JAMA Neurology · 2020 · 133 citations · Full text

Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation

Hideyuki Yoshida, Akihiro Kimura, Tomohiro Fukaya et al. · Biochemical and Biophysical Research Communications · 2012 · 60 citations

Low Dose Cp-690,550, Autoimmune Disease, Medicine +11

Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance

Yan Zhou, Xiao Leng, Shasha Luo et al. · Journal of Immunology Research · 2016 · 49 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +17

Pathological findings in central nervous system demyelination associated with infliximab

Alicja Kalinowska, Mahboobeh Fereidan-Esfahani, Yong Guo et al. · Multiple Sclerosis Journal · 2019 · 20 citations · Full text